Sun Pharma ties up with Samsung BioLogics
Samsung BioLogics will manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.